Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03116009 · ClinicalTrials.gov registry record · Phase 3
Randomization of Early Diabetes Screening Among Obese Pregnant Women.
A Phase 3 study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
NCT03116009 is a Phase 3 study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 600 participants.
The verdict
NCT03116009, a Phase 3 study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
Study Summary
This will be a randomization of two groups of obese pregnant women into early screening for diabetes mellitus at the time of their first or subsequent prenatal visits before 20 weeks of gestation versus standard time of screening for diabetes at 24 - 28 weeks as it is done for all pregnant women. The perinatal outcomes between the two groups will be compared to determine whether early screening for diabetes in all obese pregnant women has a clinical merit or significant.
Interventions
- DRUG Screening for diabetes with 1-hour GCT and HbA1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2017-03-19 |
| Est. Completion | 2019-11-25 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03116009
The ClinicalTrials.gov registry entry for NCT03116009 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Screening for diabetes with 1-hour GCT and HbA1 is the first listed.
NCT03116009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03116009 about?
NCT03116009 is a clinical study titled "Randomization of Early Diabetes Screening Among Obese Pregnant Women.". This will be a randomization of two groups of obese pregnant women into early screening for diabetes mellitus at the time of their first or subsequent prenatal visits before 20 weeks of gestation versus standard time of screening for diabetes at 24 - 28 weeks as it is done for all pregnant women. Th...
What is the current status of trial NCT03116009?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2017-03-19. Estimated completion is 2019-11-25.
What interventions are being tested in trial NCT03116009?
The interventions under investigation include: Screening for diabetes with 1-hour GCT and HbA1 (DRUG).
Who is sponsoring clinical trial NCT03116009?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.